T. Rowe Price Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273M | Sell |
|
|||||
|
2025
Q1 | $548M | Buy |
|
|||||
|
2024
Q4 | $501M | Sell |
|
|||||
|
2024
Q3 | $606M | Buy |
|
|||||
|
2024
Q2 | $478M | Sell |
|
|||||
|
2024
Q1 | $698M | Sell |
|
|||||
|
2023
Q4 | $879M | Sell |
|
|||||
|
2023
Q3 | $1.63B | Buy |
|
|||||
|
2023
Q2 | $1.2B | Sell |
|
|||||
|
2023
Q1 | $1.51B | Buy |
|
|||||
|
2022
Q4 | $1.84B | Sell |
|
|||||
|
2022
Q3 | $1.6B | Buy |
|
|||||
|
2022
Q2 | $1.83B | Sell |
|
|||||
|
2022
Q1 | $1.83B | Sell |
|
|||||
|
2021
Q4 | $2.55B | Buy |
|
|||||
|
2021
Q3 | $1.69B | Buy |
|
|||||
|
2021
Q2 | $951M | Buy |
|
|||||
|
2021
Q1 | $843M | Sell |
|
|||||
|
2020
Q4 | $1.16B | Sell |
|
|||||
|
2020
Q3 | $1.46B | Sell |
|
|||||
|
2020
Q2 | $1.55B | Sell |
|
|||||
|
2020
Q1 | $1.66B | Sell |
|
|||||
|
2019
Q4 | $2.32B | Sell |
|
|||||
|
2019
Q3 | $2.14B | Sell |
|
|||||
|
2019
Q2 | $4.05B | Sell |
|
|||||
|
2019
Q1 | $4.55B | Sell |
|
|||||
|
2018
Q4 | $4.81B | Buy |
|
|||||
|
2018
Q3 | $3.88B | Buy |
|
|||||
|
2018
Q2 | $2.71B | Buy |
|
|||||
|
2018
Q1 | $2.31B | Buy |
|
|||||
|
2017
Q4 | $2.25B | Sell |
|
|||||
|
2017
Q3 | $2.22B | Buy |
|
|||||
|
2017
Q2 | $2B | Sell |
|
|||||
|
2017
Q1 | $2.51B | Sell |
|
|||||
|
2016
Q4 | $2.63B | Sell |
|
|||||
|
2016
Q3 | $3.16B | Sell |
|
|||||
|
2016
Q2 | $3.85B | Sell |
|
|||||
|
2016
Q1 | $4.04B | Buy |
|
|||||
|
2015
Q4 | $3.63B | Buy |
|
|||||
|
2015
Q3 | $3.29B | Buy |
|
|||||
|
2015
Q2 | $3.4B | Buy |
|
|||||
|
2015
Q1 | $3.07B | Buy |
|
|||||
|
2014
Q4 | $2.74B | Buy |
|
|||||
|
2014
Q3 | $2.38B | Sell |
|
|||||
|
2014
Q2 | $2.48B | Sell |
|
|||||
|
2014
Q1 | $3.37B | Sell |
|
|||||
|
2013
Q4 | $3.27B | Sell |
|
|||||
|
2013
Q3 | $3.33B | Buy |
|
|||||
|
2013
Q2 | $3.21B | Buy |
|